Gary Lawrence

Gary Lawrence is an accomplished pharmaceutical development professional with extensive experience in advancing topical products and dermatological treatments. Currently serving as the Associate Vice President of Pharmaceutical Development Topicals at Incyte since January 2023, Gary focuses on enhancing product offerings that improve patient outcomes. Prior roles include Executive Director at Incyte, Senior Director at VYNE Therapeutics, and various leadership positions at Stiefel, a GSK company, where responsibilities encompassed managing multimillion-dollar budgets and overseeing product development from concept to launch. Gary's foundational experience in product development dates back to positions held at Bioglan Laboratories Ltd, SmithKline Beecham Corporation, and Pitman-Moore (Veterinary) Ltd. Gary's educational background includes a Bachelor of Science in Advanced Chemistry and qualifications in Analytical Chemistry and Applied Chemistry from the University of West London and the University of Hertfordshire.